Global Biomarkers Market By Type (Safety Biomarkers, Efficacy Biomarkers, Predictive Biomarkers, Surrogate Biomarkers, Pharmacodynamic Biomarkers, Prognostics Biomarkers, Validation Biomarkers) By Product (Consumable, Services, Software) By Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, Others) By Disease (Cancer,Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Others) Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Sep 2024
Report ID: 129675
Number of Pages:
Format:

Table of Contents
- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Biomarkers Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Biomarkers Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Biomarkers Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 3.3. Global Biomarkers Market Attractiveness Analysis, By Type
    3.3.1. Safety Biomarkers
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Efficacy Biomarkers
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
    3.3.3. Validation Biomarkers
    3.3.3.1. Insights
    3.3.3.2. Key Takeaways
  - 3.4. Global Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  - 3.5. Global Biomarkers Market Attractiveness Analysis, By Product
    3.5.1. Consumable
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Services
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Software
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
  - 3.6. Global Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 3.7. Global Biomarkers Market Attractiveness Analysis, By Application
    3.7.1. Diagnostics
    3.7.1.1. Insights
    3.7.1.2. Key Takeaways
    3.7.2. Drug Discovery & Development
    3.7.2.1. Insights
    3.7.2.2. Key Takeaways
    3.7.3. Personalized Medicine
    3.7.3.1. Insights
    3.7.3.2. Key Takeaways
    3.7.4. Disease Risk Assessment
    3.7.4.1. Insights
    3.7.4.2. Key Takeaways
    3.7.5. Others
    3.7.5.1. Insights
    3.7.5.2. Key Takeaways
  - 3.8. Global Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease, 2019-2033
  - 3.9. Global Biomarkers Market Attractiveness Analysis, By Disease
    3.9.1. Cancer
    3.9.1.1. Insights
    3.9.1.2. Key Takeaways
    3.9.2. Cardiovascular Diseases
    3.9.2.1. Insights
    3.9.2.2. Key Takeaways
    3.9.3. Neurological Diseases
    3.9.3.1. Insights
    3.9.3.2. Key Takeaways
    3.9.4. Immunological Diseases
    3.9.4.1. Insights
    3.9.4.2. Key Takeaways
    3.9.5. Others
    3.9.5.1. Insights
    3.9.5.2. Key Takeaways
    3.9.5.3.
- 4. Global Biomarkers Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Biomarkers Market Attractiveness Analysis, By Region
- 5. North America Biomarkers Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 5.3. North America Biomarkers Market Attractiveness Analysis, By Type
  - 5.4. North America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  - 5.5. North America Biomarkers Market Attractiveness Analysis, By Product
  - 5.6. North America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 5.7. North America Biomarkers Market Attractiveness Analysis, By Application
  - 5.8. North America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease, 2019-2033
  - 5.9. North America Biomarkers Market Attractiveness Analysis, By Disease
  - 5.10. North America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.11. North America Biomarkers Market Attractiveness Analysis, By Country
    5.11.1. The US
    5.11.2. Canada
- 6. Europe Biomarkers Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 6.3. Europe Biomarkers Market Attractiveness Analysis, By Type
  - 6.4. Europe Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  - 6.5. Europe Biomarkers Market Attractiveness Analysis, By Product
  - 6.6. Europe Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 6.7. Europe Biomarkers Market Attractiveness Analysis, By Application
  - 6.8. Europe Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease, 2019-2033
  - 6.9. Europe Biomarkers Market Attractiveness Analysis, By Disease
  - 6.10. Europe Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.11. Europe Biomarkers Market Attractiveness Analysis, By Country
    6.11.1. Germany
    6.11.2. The UK
    6.11.3. France
    6.11.4. Spain
    6.11.5. Italy
    6.11.6. Russia
    6.11.7. Netherland
    6.11.8. Rest of Europe
- 7. Asia Pacific Biomarkers Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 7.3. Asia Pacific Biomarkers Market Attractiveness Analysis, By Type
  - 7.4. Asia Pacific Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  - 7.5. Asia Pacific Biomarkers Market Attractiveness Analysis, By Product
  - 7.6. Asia Pacific Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 7.7. Asia Pacific Biomarkers Market Attractiveness Analysis, By Application
  - 7.8. Asia Pacific Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease, 2019-2033
  - 7.9. Asia Pacific Biomarkers Market Attractiveness Analysis, By Disease
  - 7.10. Asia Pacific Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.11. Asia Pacific Biomarkers Market Attractiveness Analysis, By Country
    7.11.1. China
    7.11.2. Japan
    7.11.3. South Korea
    7.11.4. India
    7.11.5. Australia
    7.11.6. New Zealand
    7.11.7. Singapore
    7.11.8. Thailand
    7.11.9. Vietnam
    7.11.10. Rest of Asia Pacific
- 8. Latin America Biomarkers Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 8.3. Latin America Biomarkers Market Attractiveness Analysis, By Type
  - 8.4. Latin America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  - 8.5. Latin America Biomarkers Market Attractiveness Analysis, By Product
  - 8.6. Latin America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 8.7. Latin America Biomarkers Market Attractiveness Analysis, By Application
  - 8.8. Latin America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease, 2019-2033
  - 8.9. Latin America Biomarkers Market Attractiveness Analysis, By Disease
  - 8.10. Latin America Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.11. Latin America Biomarkers Market Attractiveness Analysis, By Country
    8.11.1. Brazil
    8.11.2. Mexico
    8.11.3. Rest of Latin America
- 9. Middle East & Africa Biomarkers Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Type, 2019-2033
  - 9.3. Middle East & Africa Biomarkers Market Attractiveness Analysis, By Type
  - 9.4. Middle East & Africa Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
  - 9.5. Middle East & Africa Biomarkers Market Attractiveness Analysis, By Product
  - 9.6. Middle East & Africa Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 9.7. Middle East & Africa Biomarkers Market Attractiveness Analysis, By Application
  - 9.8. Middle East & Africa Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Disease, 2019-2033
  - 9.9. Middle East & Africa Biomarkers Market Attractiveness Analysis, By Disease
  - 9.10. Middle East & Africa Biomarkers Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.11. Middle East & Africa Biomarkers Market Attractiveness Analysis, By Country
    9.11.1. South Africa
    9.11.2. Saudi Arabia
    9.11.3. UAE
    9.11.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. F. Hoffmann-La Roche AG
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. Epigenomics AG
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Abbott
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Thermo Fisher Scientific Inc
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. General Electric
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. Eurofins Scientific
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Johnson & Johnson Services, Inc.
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. QIAGEN
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Bio-Rad Laboratories, Inc.
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
    10.7.10. Siemens Healthineers AG
    10.7.10.1. Company Details
    10.7.10.2. Business Overview
    10.7.10.3. Product Portfolio
    10.7.10.4. Financial Insights
    10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.10.6. SWOT Analysis
    10.7.10.7. Geographic Footprint
    10.7.11. Merck KGaA
    10.7.11.1. Company Details
    10.7.11.2. Business Overview
    10.7.11.3. Product Portfolio
    10.7.11.4. Financial Insights
    10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.11.6. SWOT Analysis
    10.7.11.7. Geographic Footprint
    10.7.12. PerkinElmer Inc.
    10.7.12.1. Company Details
    10.7.12.2. Business Overview
    10.7.12.3. Product Portfolio
    10.7.12.4. Financial Insights
    10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.12.6. SWOT Analysis
    10.7.12.7. Geographic Footprint
    10.7.13. Agilent Technologies, Inc.
    10.7.13.1. Company Details
    10.7.13.2. Business Overview
    10.7.13.3. Product Portfolio
    10.7.13.4. Financial Insights
    10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.13.6. SWOT Analysis
    10.7.13.7. Geographic Footprint
    10.7.14. Other Key Players
    10.7.14.1. Company Details
    10.7.14.2. Business Overview
    10.7.14.3. Product Portfolio
    10.7.14.4. Financial Insights
    10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.14.6. SWOT Analysis
    10.7.14.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
List of Tables
- Table 1. Global Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 2. Global Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 3. Global Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 4. Global Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 5. Global Biomarkers Market Value (US$ Mn), By Region, 2019-2033
- Table 6. North America Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 7. North America Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 8. North America Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 9. North America Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 10. North America Biomarkers Market Value (US$ Mn), By Country, 2019-2033
- Table 11. The US Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 12. The US Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 13. The US Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 14. The US Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 15. Canada Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 16. Canada Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 17. Canada Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 18. Canada Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 19. Europe Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 20. Europe Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 21. Europe Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 22. Europe Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 23. Europe Biomarkers Market Value (US$ Mn), By Country, 2019-2033
- Table 24. Germany Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 25. Germany Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 26. Germany Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 27. Germany Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 28. The UK Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 29. The UK Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 30. The UK Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 31. The UK Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 32. France Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 33. France Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 34. France Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 35. France Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 36. Spain Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 37. Spain Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 38. Spain Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 39. Spain Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 40. Italy Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 41. Italy Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 42. Italy Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 43. Italy Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 44. Russia Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 45. Russia Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 46. Russia Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 47. Russia Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 48. Netherland Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 49. Netherland Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 50. Netherland Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 51. Netherland Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 52. Rest of Europe Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 53. Rest of Europe Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 54. Rest of Europe Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 55. Rest of Europe Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 56. Asia Pacific Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 57. Asia Pacific Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 58. Asia Pacific Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 59. Asia Pacific Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 60. Asia Pacific Biomarkers Market Value (US$ Mn), By Country, 2019-2033
- Table 61. China Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 62. China Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 63. China Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 64. China Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 65. India Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 66. India Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 67. India Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 68. India Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 69. Japan Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 70. Japan Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 71. Japan Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 72. Japan Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 73. South Korea Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 74. South Korea Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 75. South Korea Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 76. South Korea Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 77. Australia Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 78. Australia Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 79. Australia Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 80. Australia Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 81. New Zealand Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 82. New Zealand Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 83. New Zealand Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 84. New Zealand Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 85. Singapore Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 86. Singapore Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 87. Singapore Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 88. Singapore Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 89. Thailand Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 90. Thailand Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 91. Thailand Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 92. Thailand Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 93. Vietnam Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 94. Vietnam Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 95. Vietnam Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 96. Vietnam Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 97. Rest of Asia Pacific Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 98. Rest of Asia Pacific Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 99. Rest of Asia Pacific Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 100. Rest of Asia Pacific Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 101. Latin America Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 102. Latin America Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 103. Latin America Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 104. Latin America Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 105. Latin America Biomarkers Market Value (US$ Mn), By Country, 2019-2033
- Table 106. Brazil Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 107. Brazil Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 108. Brazil Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 109. Brazil Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 110. Mexico Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 111. Mexico Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 112. Mexico Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 113. Mexico Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 114. Rest of Latin America Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 115. Rest of Latin America Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 116. Rest of Latin America Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 117. Rest of Latin America Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 118. Middle East & Africa Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 119. Middle East & Africa Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 120. Middle East & Africa Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 121. Middle East & Africa Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 122. Middle East & Africa Biomarkers Market Value (US$ Mn), By Country, 2019-2033
- Table 123. South Africa Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 124. South Africa Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 125. South Africa Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 126. South Africa Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 127. Saudi Arabia Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 128. Saudi Arabia Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 129. Saudi Arabia Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 130. Saudi Arabia Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 131. UAE Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 132. UAE Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 133. UAE Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 134. UAE Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
- Table 135. Rest of Middle East & Africa Biomarkers Market Value (US$ Mn), By Type, 2019-2033
- Table 136. Rest of Middle East & Africa Biomarkers Market Value (US$ Mn), By Product, 2019-2033
- Table 137. Rest of Middle East & Africa Biomarkers Market Value (US$ Mn), By Application, 2019-2033
- Table 138. Rest of Middle East & Africa Biomarkers Market Value (US$ Mn), By Disease, 2019-2033
List of Figures
- Figure 1. Global Biomarkers Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in the Biomarkers Market
- Figure 5. Global Biomarkers Market Analysis, By Type, 2019, 2023 and 2033
- Figure 6. Global Biomarkers Market Attractiveness Analysis, By Type
- Figure 7. Global Biomarkers Market Analysis, By Product, 2019, 2023 and 2033
- Figure 8. Global Biomarkers Market Attractiveness Analysis, By Product
- Figure 9. Global Biomarkers Market Analysis, By Application, 2019, 2023 and 2033
- Figure 10. Global Biomarkers Market Attractiveness Analysis, By Application
- Figure 11. Global Biomarkers Market Analysis, By Disease, 2019, 2023 and 2033
- Figure 12. Global Biomarkers Market Attractiveness Analysis, By Disease
- Figure 13. Global Biomarkers Market Analysis, By Region, 2019, 2023 and 2033
- Figure 14. Global Biomarkers Market Attractiveness Analysis, By Region
- Figure 15. North America Biomarkers Market Analysis, By Type, 2019, 2023 and 2033
- Figure 16. North America Biomarkers Market Attractiveness Analysis, By Type
- Figure 17. North America Biomarkers Market (US$ Mn), by Safety Biomarkers, 2019-2033
- Figure 18. North America Biomarkers Market (US$ Mn), by Efficacy Biomarkers, 2019-2033
- Figure 19. North America Biomarkers Market (US$ Mn), by Validation Biomarkers, 2019-2033
- Figure 20. North America Biomarkers Market Analysis, By Product, 2019, 2023 and 2033
- Figure 21. North America Biomarkers Market Attractiveness Analysis, By Product
- Figure 22. North America Biomarkers Market (US$ Mn), by Consumable, 2019-2033
- Figure 23. North America Biomarkers Market (US$ Mn), by Services, 2019-2033
- Figure 24. North America Biomarkers Market (US$ Mn), by Software, 2019-2033
- Figure 25. North America Biomarkers Market Analysis, By Application, 2019, 2023 and 2033
- Figure 26. North America Biomarkers Market Attractiveness Analysis, By Application
- Figure 27. North America Biomarkers Market (US$ Mn), by Diagnostics, 2019-2033
- Figure 28. North America Biomarkers Market (US$ Mn), by Drug Discovery & Development, 2019-2033
- Figure 29. North America Biomarkers Market (US$ Mn), by Personalized Medicine, 2019-2033
- Figure 30. North America Biomarkers Market (US$ Mn), by Disease Risk Assessment, 2019-2033
- Figure 31. North America Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 32. North America Biomarkers Market Analysis, By Disease, 2019, 2023 and 2033
- Figure 33. North America Biomarkers Market Attractiveness Analysis, By Disease
- Figure 34. North America Biomarkers Market (US$ Mn), by Cancer, 2019-2033
- Figure 35. North America Biomarkers Market (US$ Mn), by Cardiovascular Diseases, 2019-2033
- Figure 36. North America Biomarkers Market (US$ Mn), by Neurological Diseases, 2019-2033
- Figure 37. North America Biomarkers Market (US$ Mn), by Immunological Diseases, 2019-2033
- Figure 38. North America Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 39. North America Biomarkers Market Analysis, By Country, 2019, 2023 and 2033
- Figure 40. North America Biomarkers Market Attractiveness Analysis, By Country
- Figure 41. Europe Biomarkers Market Analysis, By Type, 2019, 2023 and 2033
- Figure 42. Europe Biomarkers Market Attractiveness Analysis, By Type
- Figure 43. Europe Biomarkers Market (US$ Mn), by Safety Biomarkers, 2019-2033
- Figure 44. Europe Biomarkers Market (US$ Mn), by Efficacy Biomarkers, 2019-2033
- Figure 45. Europe Biomarkers Market (US$ Mn), by Validation Biomarkers, 2019-2033
- Figure 46. Europe Biomarkers Market Analysis, By Product, 2019, 2023 and 2033
- Figure 47. Europe Biomarkers Market Attractiveness Analysis, By Product
- Figure 48. Europe Biomarkers Market (US$ Mn), by Consumable, 2019-2033
- Figure 49. Europe Biomarkers Market (US$ Mn), by Services, 2019-2033
- Figure 50. Europe Biomarkers Market (US$ Mn), by Software, 2019-2033
- Figure 51. Europe Biomarkers Market Analysis, By Application, 2019, 2023 and 2033
- Figure 52. Europe Biomarkers Market Attractiveness Analysis, By Application
- Figure 53. Europe Biomarkers Market (US$ Mn), by Diagnostics, 2019-2033
- Figure 54. Europe Biomarkers Market (US$ Mn), by Drug Discovery & Development, 2019-2033
- Figure 55. Europe Biomarkers Market (US$ Mn), by Personalized Medicine, 2019-2033
- Figure 56. Europe Biomarkers Market (US$ Mn), by Disease Risk Assessment, 2019-2033
- Figure 57. Europe Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 58. Europe Biomarkers Market Analysis, By Disease, 2019, 2023 and 2033
- Figure 59. Europe Biomarkers Market Attractiveness Analysis, By Disease
- Figure 60. Europe Biomarkers Market (US$ Mn), by Cancer, 2019-2033
- Figure 61. Europe Biomarkers Market (US$ Mn), by Cardiovascular diseases, 2019-2033
- Figure 62. Europe Biomarkers Market (US$ Mn), by Neurological Diseases, 2019-2033
- Figure 63. Europe Biomarkers Market (US$ Mn), by Immunological Diseases, 2019-2033
- Figure 64. Europe Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 65. Europe Biomarkers Market Analysis, By Country, 2019, 2023 and 2033
- Figure 66. Europe Biomarkers Market Attractiveness Analysis, By Country
- Figure 67. Asia Pacific Biomarkers Market Analysis, By Type, 2019, 2023 and 2033
- Figure 68. Asia Pacific Biomarkers Market Attractiveness Analysis, By Type
- Figure 69. Asia Pacific Biomarkers Market (US$ Mn), by Safety Biomarkers, 2019-2033
- Figure 70. Asia Pacific Biomarkers Market (US$ Mn), by Efficacy Biomarkers, 2019-2033
- Figure 71. Asia Pacific Biomarkers Market (US$ Mn), by Validation Biomarkers, 2019-2033
- Figure 72. Asia Pacific Biomarkers Market Analysis, By Product, 2019, 2023 and 2033
- Figure 73. Asia Pacific Biomarkers Market Attractiveness Analysis, By Product
- Figure 74. Asia Pacific Biomarkers Market (US$ Mn), by Consumable, 2019-2033
- Figure 75. Asia Pacific Biomarkers Market (US$ Mn), by Services, 2019-2033
- Figure 76. Asia Pacific Biomarkers Market (US$ Mn), by Software, 2019-2033
- Figure 77. Asia Pacific Biomarkers Market Analysis, By Application, 2019, 2023 and 2033
- Figure 78. Asia Pacific Biomarkers Market Attractiveness Analysis, By Application
- Figure 79. Asia Pacific Biomarkers Market (US$ Mn), by Diagnostics, 2019-2033
- Figure 80. Asia Pacific Biomarkers Market (US$ Mn), by Drug Discovery & Development, 2019-2033
- Figure 81. Asia Pacific Biomarkers Market (US$ Mn), by Personalized Medicine, 2019-2033
- Figure 82. Asia Pacific Biomarkers Market (US$ Mn), by Disease Risk Assessment, 2019-2033
- Figure 83. Asia Pacific Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 84. Asia Pacific Biomarkers Market Analysis, By Disease, 2019, 2023 and 2033
- Figure 85. Asia Pacific Biomarkers Market Attractiveness Analysis, By Disease
- Figure 86. Asia Pacific Biomarkers Market (US$ Mn), by Cancer, 2019-2033
- Figure 87. Asia Pacific Biomarkers Market (US$ Mn), by Cardiovascular diseases, 2019-2033
- Figure 88. Asia Pacific Biomarkers Market (US$ Mn), by Neurological Diseases, 2019-2033
- Figure 89. Asia Pacific Biomarkers Market (US$ Mn), by Immunological Diseases, 2019-2033
- Figure 90. Asia Pacific Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 91. Asia Pacific Biomarkers Market Analysis, By Country, 2019, 2023 and 2033
- Figure 92. Asia Pacific Biomarkers Market Attractiveness Analysis, By Country
- Figure 93. Latin America Biomarkers Market Analysis, By Type, 2019, 2023 and 2033
- Figure 94. Latin America Biomarkers Market Attractiveness Analysis, By Type
- Figure 95. Latin America Biomarkers Market (US$ Mn), by Safety Biomarkers, 2019-2033
- Figure 96. Latin America Biomarkers Market (US$ Mn), by Efficacy Biomarkers, 2019-2033
- Figure 97. Latin America Biomarkers Market (US$ Mn), by Validation Biomarkers, 2019-2033
- Figure 98. Latin America Biomarkers Market Analysis, By Product, 2019, 2023 and 2033
- Figure 99. Latin America Biomarkers Market Attractiveness Analysis, By Product
- Figure 100. Latin America Biomarkers Market (US$ Mn), by Consumable, 2019-2033
- Figure 101. Latin America Biomarkers Market (US$ Mn), by Services, 2019-2033
- Figure 102. Latin America Biomarkers Market (US$ Mn), by Software, 2019-2033
- Figure 103. Latin America Biomarkers Market Analysis, By Application, 2019, 2023 and 2033
- Figure 104. Latin America Biomarkers Market Attractiveness Analysis, By Application
- Figure 105. Latin America Biomarkers Market (US$ Mn), by Diagnostics, 2019-2033
- Figure 106. Latin America Biomarkers Market (US$ Mn), by Drug Discovery & Development, 2019-2033
- Figure 107. Latin America Biomarkers Market (US$ Mn), by Personalized Medicine, 2019-2033
- Figure 108. Latin America Biomarkers Market (US$ Mn), by Disease Risk Assessment, 2019-2033
- Figure 109. Latin America Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 110. Latin America Biomarkers Market Analysis, By Disease, 2019, 2023 and 2033
- Figure 111. Latin America Biomarkers Market Attractiveness Analysis, By Disease
- Figure 112. Latin America Biomarkers Market (US$ Mn), by Cancer, 2019-2033
- Figure 113. Latin America Biomarkers Market (US$ Mn), by Cardiovascular diseases, 2019-2033
- Figure 114. Latin America Biomarkers Market (US$ Mn), by Neurological Diseases, 2019-2033
- Figure 115. Latin America Biomarkers Market (US$ Mn), by Immunological Diseases, 2019-2033
- Figure 116. Latin America Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 117. Latin America Biomarkers Market Analysis, By Country, 2019, 2023 and 2033
- Figure 118. Latin America Biomarkers Market Attractiveness Analysis, By Country
- Figure 119. Middle East and Africa Biomarkers Market Analysis, By Type, 2019, 2023 and 2033
- Figure 120. Middle East and Africa Biomarkers Market Attractiveness Analysis, By Type
- Figure 121. Middle East and Africa Biomarkers Market (US$ Mn), by Safety Biomarkers, 2019-2033
- Figure 122. Middle East and Africa Biomarkers Market (US$ Mn), by Efficacy Biomarkers, 2019-2033
- Figure 123. Middle East and Africa Biomarkers Market (US$ Mn), by Validation Biomarkers, 2019-2033
- Figure 124. Middle East and Africa Biomarkers Market Analysis, By Product, 2019, 2023 and 2033
- Figure 125. Middle East and Africa Biomarkers Market Attractiveness Analysis, By Product
- Figure 126. Middle East and Africa Biomarkers Market (US$ Mn), by Consumable, 2019-2033
- Figure 127. Middle East and Africa Biomarkers Market (US$ Mn), by Services, 2019-2033
- Figure 128. Middle East and Africa Biomarkers Market (US$ Mn), by Software, 2019-2033
- Figure 129. Middle East and Africa Biomarkers Market Analysis, By Application, 2019, 2023 and 2033
- Figure 130. Middle East and Africa Biomarkers Market Attractiveness Analysis, By Application
- Figure 131. Middle East and Africa Biomarkers Market (US$ Mn), by Diagnostics, 2019-2033
- Figure 132. Middle East and Africa Biomarkers Market (US$ Mn), by Drug Discovery & Development, 2019-2033
- Figure 133. Middle East and Africa Biomarkers Market (US$ Mn), by Personalized Medicine, 2019-2033
- Figure 134. Middle East and Africa Biomarkers Market (US$ Mn), by Disease Risk Assessment, 2019-2033
- Figure 135. Middle East and Africa Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 136. Middle East and Africa Biomarkers Market Analysis, By Disease, 2019, 2023 and 2033
- Figure 137. Middle East and Africa Biomarkers Market Attractiveness Analysis, By Disease
- Figure 138. Middle East and Africa Biomarkers Market (US$ Mn), by Cancer, 2019-2033
- Figure 139. Middle East and Africa Biomarkers Market (US$ Mn), by Cardiovascular diseases, 2019-2033
- Figure 140. Middle East and Africa Biomarkers Market (US$ Mn), by Neurological Diseases, 2019-2033
- Figure 141. Middle East and Africa Biomarkers Market (US$ Mn), by Immunological Diseases, 2019-2033
- Figure 142. Middle East and Africa Biomarkers Market (US$ Mn), by Others, 2019-2033
- Figure 143. Middle East and Africa Biomarkers Market Analysis, By Country, 2019, 2023 and 2033
- Figure 144. Middle East and Africa Biomarkers Market Attractiveness Analysis, By Country
- F. Hoffmann-La Roche AG
- Epigenomics AG
- Abbott Laboratories
- Thermo Fisher Scientific Company Profile
- General Electric
- Eurofins Scientific
- Johnson & Johnson Services, Inc.
- QIAGEN NV Company Profile
- Bio-Rad Laboratories, Inc. Company Profile
- Siemens Healthineers AG
- Merck KGaA Company Profile
- PerkinElmer Inc.
- Agilent Technologies, Inc.
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)

Table of Contents

List of Tables

List of Figures

Related Reports

Our Clients